Medical Device | September 20, 2022
Siemens Healthineers expands its offerings in India
Expanding precision medicine, ARTIS icono is designed to enable a wide procedure mix in a single interventional suite
Expanding precision medicine, ARTIS icono is designed to enable a wide procedure mix in a single interventional suite
The reliability of their products, evidenced by their inclusion in the WHO emergency use list, has further improved with the addition of Takara Bio's enzymes.
The Phase 3 SOLO-1 trial demonstrated 67% of advanced ovarian cancer patients with BRCA mutations receiving LYNPARZA were alive at seven years versus 47% of placebo patients
India is at the forefront of research in cardiology worldwide but making indigenous products is what we are lacking & it needs to be improved
Philips AI-powered interventional and diagnostic smart systems enhances diagnostic confidence, drive greater efficiency, and improve patient outcomes
The drive also conducted a mega health camp, cancer screening for women and men, ENT screening for children, and blood donation drive
99% of Pristyn Doctors are using EMR facility on its doctor app
First and only PARP inhibitor to improve invasive disease-free survival, the primary endpoint, and overall survival, a key secondary endpoint of the OlympiA trial, in these patients
Lynparza is the first and only approved PARPi targeting BRCA-mutated HER2-negative high-risk early breast cancer
~96% decline reported in Malaria cases in Madhya Pradesh, due to public-private-people partnership
Subscribe To Our Newsletter & Stay Updated
